Key references

1.. Noell WK, Walker VS, Kang BS, et al: Retinal damage by light in rats. Invest Ophthalmol  1966; 5:450-473.

9.. Grimm C, Reme CE, Rol PO, et al: Blue light's effects on rhodopsin: photoreversal of bleaching in living rat eyes. Invest Ophthalmol Vis Sci  2000; 41:3984-3990.

15.. Klein R, Klein BE, Jensen SC, et al: The five-year incidence and progression of age-related maculopathy: the Beaver Dam eye study. Ophthalmology  1997; 104:7-21.

17.. Zhou J, Jang YP, Kim SR, et al: Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci  2006; 103:16182-16187.

20.. Vaughan DK, Nemke JL, Fliesler SJ, et al: Evidence for a circadian rhythm of susceptibility to retinal light damage. Photochem Photobiol  2002; 75:547-553.

25.. Marc RE, Jones CB, Vazquez-Chona F, et al: Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration. Mol Vis  2008; 14:782-806.

30.. Heckenlively JR, Rodriguez JA, Daiger SP: Autosomal dominant sectoral retinitis pigmentosa: two families with a transversion mutation in codon 23 of rhodopsin. Arch Ophthalmol  1991; 109:84-91.

31.. Machida S, Kondo M, Jamison JA, et al: P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci  2000; 41:3200-3209.

40.. Sieving PA, Chaudry P, Kondo M, et al: Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isoretinoin therapy. Proc Natl Acad Sci  2001; 98:1835-1840.

50.. Birch EE, Hoffman DR, Castaneda YS, et al: A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am J Clin Nutr  2002; 75:570-580.

52.. Mukherjee PK, Marcheselli VL, Serhan CN, et al: Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci  2004; 101:8491-8496.

54.. Crabb JW, Miyagi M, Gu X, et al: Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci  2002; 99:14682-14687.

71.. Organisciak DT, Darrow RM, Barsalou L, et al: Circadian dependent retinal light damage in rats. Invest Ophthalmol Vis Sci  2000; 41:3694-3701.

79.. AREDS #8. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol  2001; 119:1417-1436.

92.. Zarbin MA: Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol  2004; 122:598-614.